1107 Pilin
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Lipids and lipid-like molecules | 2 | 0.3 | 6.07× | not tested | |
| Organic acids and derivatives | 1 | 0.5 | 2.19× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02043 | LHG | 1,2-Dipalmitoyl-Phosphatidyl-Glycerole | 121 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| LHG | 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE | 174 |
| 6V6 | [(2~{S})-3-[[(2~{R})-2,3-bis(oxidanyl)propoxy]-oxidanyl-phosphoryl]oxy-2-hexadec-9-enoyloxy-propyl] hexadecanoate | 145 |
| KSV | (2R)-2,3-dihydroxypropyl ethyl hydrogen (S)-phosphate | 70 |
| X41 | 1-MYRISTOYL-2-MYRISTOLEOYL-SN-GLYCERO-3-PHOSPHATE | 1 |